Page last updated: 2024-12-10

propidium monoazide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propidium monoazide: a membrane impermeant dye that can cross-link DNA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035529
SCHEMBL ID17399073
MeSH IDM0527976

Synonyms (5)

Synonym
3-(3-amino-8-azido-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium
SCHEMBL17399073
propidium monoazide
Q16821519
DTXSID301045686

Research Excerpts

Overview

Propidium monoazide (PMA) is a highly selective dye that penetrates only membrane-compromised, dead microbial cells and inhibits both DNA extraction and amplification. It is used to distinguish intact from dead bacterial cells.

ExcerptReferenceRelevance
"Propidium monoazide (PMA) is a highly selective dye that penetrates only membrane-compromised, dead microbial cells and inhibits both DNA extraction and amplification. "( Applicability of propidium monoazide (PMA) for discrimination between living and dead phytoplankton cells.
Joo, S; Park, P; Park, S, 2019
)
2.3
"Propidium monoazide is a DNA-intercalating dye. "( Molecular monitoring of Escherichia coli O157: H7 sterilization rate using qPCR and propidium monoazide treatment.
Cong-Cong, L; Hui, W; Xing-Long, X; Yang, Q; Yi-Gang, Y, 2013
)
2.06
"Propidium monoazide (PMA) is a membrane-impairment dye that penetrates only membrane-damaged cells."( Quantification of viable Giardia cysts and Cryptosporidium oocysts in wastewater using propidium monoazide quantitative real-time PCR.
Alonso, JL; Amorós, I; Guy, RA, 2014
)
1.35
"Propidium monoazide (PMA) is a photoreactive DNA-binding dye that inhibits PCR amplification by DNA modification."( Evaluation of propidium monoazide real-time PCR for early detection of viable Mycobacterium tuberculosis in clinical respiratory specimens.
Chang, CL; Kim, HH; Kim, SS; Kim, YJ; Lee, EY; Lee, SM; Park, BK; Yi, J, 2014
)
1.48
"Propidium monoazide (PMA) is a DNA binding agent, that has the ability to penetrate only dead cells with compromised membranes and has been used in conjunction with real-time PCR to distinguish intact from dead bacterial cells."( Improving clinical significance of PCR: use of propidium monoazide to distinguish viable from dead Staphylococcus aureus and Staphylococcus epidermidis.
Bauer, TW; Hall, GS; Kobayashi, H; Oethinger, M; Tuohy, MJ, 2009
)
1.33
"Propidium monoazide (PMA) is a DNA-intercalating agent used to selectively detect DNA from viable cells by polymerase chain reaction (PCR). "( Sodium chloride affects propidium monoazide action to distinguish viable cells.
Barth, VC; Cattani, F; de Oliveira, SD; Ferreira, CA, 2012
)
2.13

Effects

Propidium monoazide (PMA) has been used to discriminate between live and dead cells by blocking the DNA from membrane-damaged cells from being amplified. It has been reported to penetrate dead cells following membrane damage and to cross-link DNA, thereby inhibiting DNA amplification.

ExcerptReferenceRelevance
"Propidium monoazide (PMA) qPCR has been used to differentiate DNA from viable and nonviable bacterial cells."( Detection of Viable Streptococcus equi equi Using Propidium Monoazide Polymerase Chain Reaction.
Boyle, AG; O'Shea, K; Rankin, SC; Stefanovski, D, 2023
)
1.88
"Propidium monoazide (PMA) has been used together with quantitative real-time PCR (qPCR) to enumerate live bacteria, while discriminating against the residual DNA of dead bacterial cells. "( Efficacy of Propidium Monoazide on Quantitative Real-Time PCR-Based Enumeration of Staphylococcus aureus Live Cells Treated with Various Sanitizers.
Kasuga, R; Kimura, B; Kuda, T; Miya, S; Miyamura, N; Takahashi, H, 2018
)
2.3
"Propidium monoazide (PMA) has been reported to penetrate dead cells following membrane damage and to cross-link DNA, thereby inhibiting DNA amplification."( Monitoring the prevalence of viable and dead cariogenic bacteria in oral specimens and in vitro biofilms by qPCR combined with propidium monoazide.
Ansai, T; Awano, S; Maki, K; Morikawa, K; Nakamura, S; Soh, I; Yasunaga, A; Yoshida, A, 2013
)
1.32
"Propidium monoazide (PMA) has been used to discriminate between live and dead cells by blocking the DNA from membrane-damaged cells from being amplified."( The effects of propidium monoazide treatment on the measured composition of polymicrobial biofilms after treatment with chlorhexidine.
Buijs, MJ; Crielaard, W; Exterkate, RA; Koopman, J; ten Cate, JM; Zaura, E, 2014
)
1.48
"Propidium monoazide (PMA) has been used to determine viable microorganisms for clinical and environmental samples since selected naked DNA which was covalently cross-linked by this dye could not be PCR-amplified. "( Detecting the nonviable and heat-tolerant bacteria in activated sludge by minimizing DNA from dead cells.
Guo, F; Zhang, T, 2014
)
1.85
"Propidium monoazide (PMA) has been used to overcome this problem, by preventing the amplification of DNA from membrane-damaged cells."( The effect of propidium monoazide treatment on the measured bacterial composition of clinical samples after the use of a mouthwash.
Brandt, BW; Buijs, MJ; Crielaard, W; Exterkate, RA; Koopman, JE; Ten Cate, JM; Zaura, E, 2015
)
1.5
"Propidium monoazide (PMA) has been used to overcome this disadvantage."( Effect of exposure to stress conditions on propidium monoazide (PMA)-qPCR based Campylobacter enumeration in broiler carcass rinses.
Botteldoorn, N; Coucke, W; Denayer, S; Dierick, K; Duarte, A; Uyttendaele, M, 2015
)
1.4

Treatment

Propidium monoazide (PMA) treatment has been shown to be effective in preventing PCR amplification of DNA from non-viable bacteria. The aim of this study was to better understand the frequency, diversity, and distribution of viable microorganisms associated with debris collected from the International Space Station.

ExcerptReferenceRelevance
"Propidium monoazide (PMA) treatment has been shown to be effective in preventing PCR amplification of DNA from non-viable bacteria in a range of contexts."( Optimisation of a propidium monoazide based method to determine the viability of microbes in faecal slurries for transplantation.
Choo, JM; Gordon, DL; Papanicolas, LE; Rogers, GB; Wang, Y; Wesselingh, SL, 2019
)
1.57
"Propidium monoazide (PMA) treatment was proposed as an efficient approach for alleviating this limitation."( Propidium monoazide-quantitative polymerase chain reaction for viable Escherichia coli and Pseudomonas aeruginosa detection from abundant background microflora.
Gensberger, ET; Kostić, T; Sessitsch, A, 2013
)
2.55
"A propidium monoazide (PMA) treatment coupled with downstream quantitative polymerase chain reaction (qPCR) and pyrosequencing analyses was carried out to better understand the frequency, diversity, and distribution of viable microorganisms associated with debris collected from the crew quarters of the International Space Station (ISS)."( International Space Station environmental microbiome - microbial inventories of ISS filter debris.
Cisneros, J; Perry, J; Pierson, DL; Rogers, SO; Vaishampayan, P; Venkateswaran, K, 2014
)
0.96
"Propidium monoazide (PMA) treatment-based real-time PCR was used for enumeration of viable C."( Cell-free propagation of Coxiella burnetii does not affect its relative virulence.
Bossers, A; Frangoulidis, D; Jan Roest, HI; Kuley, R; Smith, HE; Smits, MA, 2015
)
1.14
"Propidium monoazide (PMA) treatment coupled with long-amplicon qPCR assays were assessed for their ability to quantify infectious MS2 in pure cultures and following inactivation by a range of UV light exposures and chlorine doses."( Evaluation of propidium monoazide and long-amplicon qPCR as an infectivity assay for coliphage.
Habash, MB; Lee, H; McLellan, NL, 2016
)
1.52
"Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing. "( Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Audebert, C; Delhaes, L; Deschaght, P; Loywick, A; Merlin, S; Nguyen, LD; Van Daele, S; Vaneechoutte, M; Viscogliosi, E, 2016
)
2.27
"Propidium Monoazide (PMA) treatment was applied to limit the analysis to the fraction of viable cells in environment."( Comparison and characterization of microbial communities in sulfide-rich wastewater with and without propidium monoazide treatment.
Guo, Y; Lin, WT; Luo, JF, 2011
)
1.31

Toxicity

ExcerptReferenceRelevance
" In contrast, the concentrations of PMA tested had no toxic effect on the viability of Vibrio cells studied."( Ethidium and propidium monoazide: comparison of potential toxicity on Vibrio sp. viability.
Bonnin-Jusserand, M; Copin, S; Grard, T; Midelet, G; Mougin, J; Raguenet, V; Robert-Pillot, A, 2021
)
0.99

Compound-Compound Interactions

A novel detection method of quantitative PCR combined with a DNA intercalating dye propidium monoazide (PMA-qPCR) was developed and then applied to analyze inactivation efficacy of chlorine and monochloramine on E. paracasei. Shifts in the bacterial community compositions in secondary effluent samples upon chlorine disinfection were investigated using Illumina MiSeq sequencing.

ExcerptReferenceRelevance
" sobrinus, using PMA combined with real-time PCR (PMA-qPCR)."( Monitoring the prevalence of viable and dead cariogenic bacteria in oral specimens and in vitro biofilms by qPCR combined with propidium monoazide.
Ansai, T; Awano, S; Maki, K; Morikawa, K; Nakamura, S; Soh, I; Yasunaga, A; Yoshida, A, 2013
)
0.6
" The aim of this study was to use propidium monoazide (PMA) combined with the quantitative polymerase chain reaction (PMA-qPCR) to selectively detect and quantify viable bacteria cells in full-scale WWTPs in China."( Quantification of viable bacteria in wastewater treatment plants by using propidium monoazide combined with quantitative PCR (PMA-qPCR).
He, M; Li, D; Lin, Y; Tong, T; Wu, S; Zeng, S, 2014
)
0.91
" Among all the methods for detecting viability, propidium monoazide (PMA) combined with real-time PCR is popular because of its specificity, sensitivity, and speed."( Enumeration of viable non-culturable Vibrio cholerae using propidium monoazide combined with quantitative PCR.
Kan, B; Liang, W; Wu, B, 2015
)
0.92
" Shifts in the bacterial community compositions in secondary effluent samples upon chlorine disinfection, both immediately and after 24 h of storage, were investigated using Illumina MiSeq sequencing combined with propidium monoazide (PMA) treatment."( Shifts of live bacterial community in secondary effluent by chlorine disinfection revealed by Miseq high-throughput sequencing combined with propidium monoazide treatment.
Hu, HY; Huo, ZY; Pang, YC; Xi, JY; Xu, Y, 2016
)
0.82
" paracasei) in fermented milk accurately and quickly, propidium monoazide combined with quantitative loop-mediated isothermal amplification (PMA-qLAMP) was applied."( Detection of viable Lacticaseibacillus paracasei in fermented milk using propidium monoazide combined with quantitative loop-mediated isothermal amplification.
Cui, L; Feng, L; Hu, L; Wang, S; Xue, Y; Zhang, D; Zhang, W, 2021
)
1.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (253)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (5.14)29.6817
2010's201 (79.45)24.3611
2020's39 (15.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.44 (24.57)
Research Supply Index5.56 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index48.61 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.39%)0.25%
Other253 (98.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]